Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies

被引：0
|
作者：
Zhitao Ying
Ting He
Xiaopei Wang
Wen Zheng
Ningjing Lin
Meifeng Tu
Yan Xie
Lingyan Ping
Chen Zhang
Weiping Liu
Lijuan Deng
Meng Wu
Feier Feng
Xin Leng
Tingting Du
Feifei Qi
Xuelian Hu
Yanping Ding
Xin-an Lu
Yuqin Song
Jun Zhu
机构：
[1] Peking University Cancer Hospital & Institute,Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing)
[2] Beijing Immunochina Pharmaceuticals Co.,undefined
[3] Ltd.,undefined
来源：
BMC Cancer | / 21卷
关键词：
CAR-T; Biodistribution; B-ALL; B-NHL; Blood;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] A single-cell atlas of CD19 chimeric antigen receptor T cells
    Li, Xubin
    Henderson, Jared
    Gordon, Max J.
    Sheikh, Irtiza
    Nastoupil, Loretta J.
    Westin, Jason
    Flowers, Christopher
    Ahmed, Sairah
    Wang, Linghua
    Neelapu, Sattva S.
    Strati, Paolo
    Deng, Qing
    Green, Michael R.
    CANCER CELL, 2023, 41 (11) : 1835 - 1837
  • [32] CD19-redirected chimeric antigen receptor-modified T cells: a promising immunotherapy for children and adults with B-cell acute lymphoblastic leukemia (ALL)
    Tasian, Sarah K.
    Gardner, Rebecca A.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2015, 6 (05) : 228 - 241
  • [33] Treatment of Chemotherapy-Refractory B-Cell Malignancies with Anti-CD19 Chimeric Antigen Receptor T Cells
    Kochenderfer, James N.
    Kassim, Sadik H.
    Somerville, Robert
    Dudley, Mark E.
    Carpenter, Robert O.
    Lu, Lily
    Feldman, Steven A.
    Morton, Kathleen E.
    Toomey, Mary Ann
    Rosenberg, Steven A.
    MOLECULAR THERAPY, 2014, 22 : S295 - S295
  • [34] Functional Characterization and Optimization of Switchable Allogeneic Chimeric Antigen Receptor T Cells for Targeting CD19 and CD20 in B Cell Malignancies
    Spehr, Johannes
    Meyer, Jan-Erik
    Loff, Simon
    Langer, Anika
    Langer, Moritz
    Boyerinas, Ben
    Le Mercier, Isabelle
    Lescarbeau, Reynald
    Cartellieri, Marc
    Ehninger, Armin
    BLOOD, 2023, 142
  • [35] Double CD19/CD22 Chimeric Antigen Receptor-Modified T Cells for the Treatment of Stage IV Relapsed and Refractory Follicular Lymphoma
    Lai, Xun
    Gu, Xuezhong
    Tsao, Shih-Ting
    Zhang, Qin
    Liu, Yu-Chen
    Jiang Yaxian
    Yan, Li
    Chun, Jun
    Zhang, Rui
    Du, Yunyun
    Gao, Xiaoli
    Yang, Yingyu
    Qiu, Xiaolian
    Fang, Mingjing
    Wei, Song
    Chang, Lung-Ji
    BLOOD, 2017, 130
  • [36] EFFECT OF A CO-STIMULATORY ENDODOMAIN ON THE PERFORMANCE OF T CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR DIRECTED AT CD19 IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL MALIGNANCIES
    Ramos, C. A.
    Savoldo, B.
    Liu, E.
    Bollard, C. M.
    Carrum, G.
    Kamble, R. T.
    Mims, M. P.
    Keating, M.
    Gee, A. P.
    Mei, Z.
    Rooney, C. M.
    Heslop, H. E.
    Brenner, M. K.
    Dotti, G.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S213 - S214
  • [37] Development of novel humanized CD19/BAFFR bicistronic chimeric antigen receptor T cells with potent antitumor activity against B-cell lineage neoplasms
    Wu, Sungui
    Luo, Qian
    Li, Feiyu
    Zhang, Suwen
    Zhang, Cuiling
    Liu, Jianwei
    Shao, Bang
    Hong, Yang
    Tan, Taochao
    Dong, Xiaoqing
    Chen, Bing
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (04) : 1361 - 1373
  • [38] Adoptive Immunotherapy for B-cell Malignancies with Autologous Chimeric Antigen Receptor Modified Tumor Targeted T Cells
    Park, Jae H.
    Brentjens, Renier J.
    DISCOVERY MEDICINE, 2010, 9 (47) : 277 - 288
  • [39] Potent Anti-leukemia Activities of Chimeric Antigen Receptor-Modified T Cells against CD19 in Chinese Patients with Relapsed/Refractory Acute Lymphocytic Leukemia
    Hu, Yongxian
    Wu, Zhao
    Luo, Yi
    Shi, Jimin
    Yu, Jian
    Pu, Chengfei
    Liang, Zuyu
    Wei, Guoqing
    Cui, Qu
    Sun, Jie
    Jiang, Jing
    Xie, Jue
    Tan, Yamin
    Ni, Wanmao
    Tu, Jifang
    Wang, Jinping
    Jin, Aiyun
    Zhang, Hao
    Cai, Zhen
    Xiao, Lei
    Huang, He
    CLINICAL CANCER RESEARCH, 2017, 23 (13) : 3297 - 3306
  • [40] Chimeric Antigen Receptor-Modified T Cells in CLL REPLY
    Urba, Walter J.
    Longo, Dan L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (20): : 1939 - 1939
12345